Influenza Vaccine


Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5



Influenza Vaccine Library
Library Home

This article was published in Pharma Business Week, which you can subscribe to online.
2007 NOV 19 -- Iomai Corporation (NASDAQ:IOMI) announced that Stanley C. Erck, the company's president and chief executive officer, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New York City on Monday, Nov. 5. Mr. Erck's presentation will begin at 9:10 a.m. Eastern Time in the Kennedy I Room of the New York Palace Hotel.

Mr. Erck's presentation will focus on Iomai's portfolio of patch-based needle-free vaccines and immunostimulants, including its plans to move into Phase 3 trials for its travelers' diarrhea vaccine and the initiation of a Phase 1/2 trial of Iomai's dose-sparing adjuvant patch for use with a pandemic influenza vaccine.

To access the live audio webcast or the subsequent archived recording, log on to the Investor Relations section on the Overview page of the Iomai website at http://www.iomai.com/. Please connect to Iomai's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

Keywords: Biotechnology, Flu Vaccines, Immunization, Influenza Vaccines, Travel Health, Travel Immunization, Travel Vaccination, Vaccination, Flu Vaccine, Iomai Corporation.

This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business Week via NewsRx.com.